KROMATID Announces Matt Hemstreet as CEO
Read More
KROMATID to Present Breakthrough Genomic Integrity Benchmarking at ASGCT 2026, Powering the World's First Genomic Intelligence Platform
Read More
WHITE PAPER: The KROMASURE Platform Assessing Genomic Structure and Genome Integrity in Cell and Gene Therapy
Read More
Watch our on-demand webinar as Erin Cross and Daniel O’Connell explore strategies for ensuring genome stability in engineered iPSC...
Read More
Explore how next-generation cytogenetic tools are redefining genomic integrity testing in cell and gene therapy. Learn how single-cell...
Read More
Learn about sample shipping instructions through our move, and about our new facility!
Read More
Explore how universal donor CAR NK cells are paving a new path in cancer treatment. Learn how CRISPR/AAV engineering, off-the-shelf NK cell...
Read More
Dive into the latest research (bioRxiv) exploring how structural variant detection refines our understanding of genomic integrity in edited...
Read More
KROMATID successfully raised $8M in its Series C round to accelerate expansion of its proprietary platforms for detecting chromosomal...
Read More
KROMATID is collaborating with a public-private-academic consortium—including the National Institute of Standards and Technology (NIST)—to...
Read More
The Genome in a Bottle Consortium (GIAB) and NIST have released the first broadly consented tumor-normal dataset, including pancreatic...
Read More
KROMATID’s directional genomic hybridization (dGH™) assay enables detection of small inverted duplications that conventional FISH and...
Read More
